ArticleOncotarget2017

Succinate dehydrogenase B-deficient cancer cells are highly sensitive to bromodomain and extra-terminal inhibitors.

Satoshi Kitazawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.